Biotech Values

[stuck_holder]

re: resverlogix (rvx.to), they do seem to have pumped this news just a bit

Dr. Roger Newton, Co-Discoverer of Lipitor(R), Joins Resverlogix Board of Directors
Monday May 14, 9:00 am ET

CALGARY, ALBERTA--(MARKET WIRE)--May 14, 2007 -- Resverlogix Corp. ("Resverlogix") (Toronto:RVX.TO - News) is pleased to announce today that the Board of Directors has appointed Roger Newton, PhD, to the Board effective July 10, 2007.

"I am very pleased to be joining the Board of Directors of Resverlogix. It is a very exciting time for the NexVas(TM) Plaque Regression technology", stated Dr. Newton. "We know that raising ApoA-l and functional HDL can regress atherosclerosis and this technology has the potential to be first in a new class of drugs for the treatment of cardiovascular disease due to atherosclerosis."

http://biz.yahoo.com/iw/070514/0252338.html

and again recently here

Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
Thursday July 12, 9:30 am ET

CALGARY, ALBERTA--(MARKET WIRE)--Jul 12, 2007 -- Resverlogix Corp. ("Resverlogix") (Toronto:RVX.TO - News) is pleased to announce today that Dr. Roger Newton has joined the Board of Directors effective immediately.

"This is a fascinating time to be joining Resverlogix's Board of Directors as momentum is gaining for the NexVas(TM) Plaque Regression technology," stated Dr. Newton. "The excitement for me comes from knowing that by raising ApoA-l and functional HDL we can regress atherosclerosis. Thus the opportunity to be first in an entire new class of drugs for the treatment of cardiovascular disease due to atherosclerosis is very appealing."

http://biz.yahoo.com/iw/070712/0277269.html

but it certainly sounds as if there is something to their "NexVas(TM) Plaque Regression technology", having been able to attract some apparently noteworthy & reputable collaborators.

the pumping seems to have had a short-lived effect on the stock price...having gone from $10.50 on april 3 to $22.50 on june 1, then back down, hitting below $10 yesterday, before closing at $10.15 Cdn

the question - does it represent a value (with about 25M shares o/s) at current price? TA suggests the possibility of a decent bounce from here, with support having held, (perhaps a good longer term entry point) while the science seems to suggest this could be more than just a short term pump (and in that regard, they have another conference call scheduled for later today at noon MDT http://biz.yahoo.com/iw/070731/0284458.html )


comments anyone?